- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/02 - Drugs for disorders of the nervous system for peripheral neuropathies
Patent holdings for IPC class A61P 25/02
Total number of patents in this class: 2207
10-year publication summary
49
|
60
|
93
|
124
|
169
|
140
|
173
|
164
|
174
|
132
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2710 |
26 |
Shionogi & Co., Ltd. | 844 |
22 |
Daiichi Sankyo Company, Limited | 1877 |
21 |
The Regents of the University of California | 20108 |
17 |
Osaka University | 3397 |
17 |
Mitsubishi Tanabe Pharma Corporation | 582 |
15 |
Vertex Pharmaceuticals Incorporated | 1626 |
14 |
Grünenthal GmbH | 565 |
14 |
Kyoto University | 2828 |
14 |
Bristol-myers Squibb Company | 4849 |
13 |
Novartis AG | 10721 |
12 |
Janssen Pharmaceutica N.V. | 3367 |
12 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
12 |
Ono Pharmaceutical Co., Ltd. | 431 |
12 |
Toray Industries, Inc. | 7000 |
11 |
King's College London | 539 |
11 |
Tenacia Biotechnology (Hong Kong) Co., Limited | 36 |
11 |
Pfizer Inc. | 3386 |
10 |
The Trustees of Columbia University in the City of New York | 3589 |
10 |
Eurofarma Laboratorios S.A. | 37 |
10 |
Other owners | 1923 |